TitleOxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid.
Publication TypeJournal Article
Year of Publication2001
AuthorsSuh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, Hagen TM
JournalFASEB J
Volume15
Issue3
Pagination700-6
Date Published2001 Mar
ISSN0892-6638
KeywordsAging, Animals, Antioxidants, Ascorbic Acid, Cells, Cultured, Dietary Supplements, DNA Damage, Fluorescent Dyes, Heart, Male, Myocardium, Oxidants, Oxidative Stress, Oxygen Consumption, Rats, Rats, Inbred F344, Thioctic Acid, Vitamin E
Abstract

Oxidative stress has been implicated as a causal factor in the aging process of the heart and other tissues. To determine the extent of age-related myocardial oxidative stress, oxidant production, antioxidant status, and oxidative DNA damage were measured in hearts of young (2 months) and old (28 months) male Fischer 344 rats. Cardiac myocytes isolated from old rats showed a nearly threefold increase in the rate of oxidant production compared to young rats, as measured by the rates of 2,7-dichlorofluorescin diacetate oxidation. Determination of myocardial antioxidant status revealed a significant twofold decline in the levels of ascorbic acid (P = 0.03), but not alpha-tocopherol. A significant age-related increase (P = 0.05) in steady-state levels of oxidative DNA damage was observed, as monitored by 8-oxo-2'-deoxyguanosine levels. To investigate whether dietary supplementation with (R)-alpha-lipoic acid (LA) was effective at reducing oxidative stress, young and old rats were fed an AIN-93M diet with or without 0.2% (w/w) LA for 2 wk before death. Cardiac myocytes from old, LA-supplemented rats exhibited a markedly lower rate of oxidant production that was no longer significantly different from that in cells from unsupplemented, young rats. Lipoic acid supplementation also restored myocardial ascorbic acid levels and reduced oxidative DNA damage. Our data indicate that the aging rat heart is under increased mitochondrial-induced oxidative stress, which is significantly attenuated by lipoic acid supplementation.

DOI10.1096/fj.00-0176com
Alternate JournalFASEB J.
PubMed ID11259388
PubMed Central IDPMC4696539
Grant ListDK48831 / DK / NIDDK NIH HHS / United States
R01 AG017141 / AG / NIA NIH HHS / United States
P30 DK026657 / DK / NIDDK NIH HHS / United States
R01 GM042056 / GM / NIGMS NIH HHS / United States
DK26657 / DK / NIDDK NIH HHS / United States
RIAG17141A / AG / NIA NIH HHS / United States
GM15431 / GM / NIGMS NIH HHS / United States
R01 DK048831 / DK / NIDDK NIH HHS / United States
P01 CA077839 / CA / NCI NIH HHS / United States
P01 GM015431 / GM / NIGMS NIH HHS / United States
R37 GM042056 / GM / NIGMS NIH HHS / United States
P50 GM015431 / GM / NIGMS NIH HHS / United States
GM42056 / GM / NIGMS NIH HHS / United States
CA77839 / CA / NCI NIH HHS / United States